Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01721304 · ClinicalTrials.gov registry record · NA
Decisionmaking for Abnormal Uterine Bleeding (AUB)
A NA study of Abnormal Uterine Bleeding, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 380
- Enrollment target
- 2
- Study locations
NCT01721304: Completed NA study of Abnormal Uterine Bleeding, sponsored by Indiana University.
NCT01721304 is a NA study of Abnormal Uterine Bleeding that has completed, run by Indiana University. The registered enrollment target is 380 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01721304, a NA study of Abnormal Uterine Bleeding, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 380 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine if using a computer survey about preferences for treatment of abnormal uterine bleeding (AUB) is useful and if it will improve patient satisfaction with clinical care and decision making. This study is a two-part study. The first pilot tests the computerized tool to ensure it is understood by patients, then the second part is a randomized study (computerized tool versus usual care) to see if improvements are made in satisfaction and if there are reductions in decision regret.
Primary Outcome
Satisfaction with care as measured by the Functional Assessment of Chronic Illness Therapy-Treatment Satisfaction-Patient Scale (FACT-TS-PS)
Conditions Studied
Interventions
- OTHER Adaptive Conjoint Analysis
Study Locations (2)
Indiana
- Indiana University - Indianapolis
North Carolina
- Southern Pines Women's Health Center - Southern Pines
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 380 participants |
| Start Date | 2009-05 |
| Est. Completion | 2012-08 |
| Phase | NA |
What the finished NCT01721304 record still lists
NCT01721304 is an interventional study that assigns participants to a tested intervention. The registered 380 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Abnormal Uterine Bleeding appearing as the primary indexed condition, and to 1 intervention - of which Adaptive Conjoint Analysis is the first listed.
NCT01721304 reports a single indexed study location in Indiana, North Carolina.
Frequently Asked Questions
What is clinical trial NCT01721304 about?
NCT01721304 is a clinical study titled "Decisionmaking for Abnormal Uterine Bleeding (AUB)". The purpose of this study is to determine if using a computer survey about preferences for treatment of abnormal uterine bleeding (AUB) is useful and if it will improve patient satisfaction with clinical care and decision making. This study is a two-part study. The first pilot tests the computerized...
What is the current status of trial NCT01721304?
This trial is currently completed. It is a NA study. The enrollment target is 380 participants. The study started on 2009-05. Estimated completion is 2012-08.
What conditions does trial NCT01721304 study?
This clinical trial studies the following conditions: Abnormal Uterine Bleeding.
What interventions are being tested in trial NCT01721304?
The interventions under investigation include: Adaptive Conjoint Analysis (OTHER).
Who is sponsoring clinical trial NCT01721304?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01721304 being conducted?
This trial has 2 study locations across Indiana, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abnormal Uterine Bleeding
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01721304's enrollment target sits among peer trials
380 273rd of 2000 higher than 1,727 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04560673 · 380 participants · Phase 2
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
- NCT04777357 · 380 participants · Phase 3
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- NCT04821154 · 380 participants
Persona Revision Knee System Outcomes
- NCT05102019 · 380 participants · NA
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia